-
Je něco špatně v tomto záznamu ?
A Telemedicine System Intervention for Patients With Type 1 Diabetes: Pilot Feasibility Crossover Intervention Study
M. Vlasakova, J. Muzik, A. Holubová, D. Fiala, E. Arsand, J. Urbanová, D. Janíčková Žďárská, M. Brabec, J. Brož
Status neindexováno Jazyk angličtina Země Kanada
Typ dokumentu časopisecké články
NLK
Directory of Open Access Journals
od 2017
PubMed Central
od 2017
Europe PubMed Central
od 2017
ProQuest Central
od 2017-01-01
Nursing & Allied Health Database (ProQuest)
od 2017-01-01
Health & Medicine (ProQuest)
od 2017-01-01
ROAD: Directory of Open Access Scholarly Resources
od 2017
PubMed
37115601
DOI
10.2196/35064
Knihovny.cz E-zdroje
- Publikační typ
- časopisecké články MeSH
BACKGROUND: Today's diabetes-oriented telemedicine systems can gather and analyze many parameters like blood glucose levels, carbohydrate intake, insulin doses, and physical activity levels (steps). Information collected can be presented to patients in a variety of graphical outputs. Despite the availability of several technical means, a large percentage of patients do not reach the goals established in their diabetes treatment. OBJECTIVE: The objective of the study was to evaluate the benefits of the Diani telemedicine system for the treatment of patients with type 1 diabetes mellitus. METHODS: Data were collected during a 24-week feasibility study. Patients responded to the World Health Organization Quality of Life - BREF (WHOQOL-BREF) questionnaire and a system evaluation questionnaire. The level of glycated hemoglobin (HbA1c) and the patient's body weight were measured, and the patient's use of the telemedicine system and their daily physical activity level were monitored. All data were sent from the patient's device to the Diani server using a real-time diabetes diary app. Wilcoxon and Friedman tests and the linear mixed effects method were used for data analysis. RESULTS: This study involved 10 patients (men: n=5; women: n=5), with a mean age of 47.7 (SD 19.3) years, a mean duration of diabetes of 10.5 (SD 8.6) years, and a mean HbA1c value of 59.5 (SD 6.7) mmol/mol. The median number of days the patients used the system was 84. After the intervention, the mean HbA1c decreased by 4.35 mmol/mol (P=.01). The patients spent 18.6 (SD 6.8) minutes on average using the app daily. After the intervention, the number of patients who measured their blood glucose level at least 3 times a day increased by 30%. The graphical visualization of the monitored parameters, automatic transmission of measured data from the glucometer, compatibility, and interconnection of individual devices when entering data were positively evaluated by patients. CONCLUSIONS: The Diani system was found to be beneficial for patients with type 1 diabetes mellitus in terms of managing their disease. Patients perceived it positively; it strengthened their knowledge of diabetes and their understanding of the influences of the measured values on the management of their disease. Its use had a positive effect on the HbA1c level.
1st Faculty of Medicine Charles University Prague Czech Republic
Institute of Computer Science Academy of Science of the Czech Republic Prague Czech Republic
Norwegian Centre for E health Research Tromsø Norway
University of Tromsø The Arctic University of Norway Tromsø Norway
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc23009889
- 003
- CZ-PrNML
- 005
- 20230721095416.0
- 007
- ta
- 008
- 230707s2023 xxc f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.2196/35064 $2 doi
- 035 __
- $a (PubMed)37115601
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxc
- 100 1_
- $a Vlasakova, Martina $u First Faculty of Medicine, Charles University, Prague, Czech Republic $1 https://orcid.org/000000017445461X
- 245 12
- $a A Telemedicine System Intervention for Patients With Type 1 Diabetes: Pilot Feasibility Crossover Intervention Study / $c M. Vlasakova, J. Muzik, A. Holubová, D. Fiala, E. Arsand, J. Urbanová, D. Janíčková Žďárská, M. Brabec, J. Brož
- 520 9_
- $a BACKGROUND: Today's diabetes-oriented telemedicine systems can gather and analyze many parameters like blood glucose levels, carbohydrate intake, insulin doses, and physical activity levels (steps). Information collected can be presented to patients in a variety of graphical outputs. Despite the availability of several technical means, a large percentage of patients do not reach the goals established in their diabetes treatment. OBJECTIVE: The objective of the study was to evaluate the benefits of the Diani telemedicine system for the treatment of patients with type 1 diabetes mellitus. METHODS: Data were collected during a 24-week feasibility study. Patients responded to the World Health Organization Quality of Life - BREF (WHOQOL-BREF) questionnaire and a system evaluation questionnaire. The level of glycated hemoglobin (HbA1c) and the patient's body weight were measured, and the patient's use of the telemedicine system and their daily physical activity level were monitored. All data were sent from the patient's device to the Diani server using a real-time diabetes diary app. Wilcoxon and Friedman tests and the linear mixed effects method were used for data analysis. RESULTS: This study involved 10 patients (men: n=5; women: n=5), with a mean age of 47.7 (SD 19.3) years, a mean duration of diabetes of 10.5 (SD 8.6) years, and a mean HbA1c value of 59.5 (SD 6.7) mmol/mol. The median number of days the patients used the system was 84. After the intervention, the mean HbA1c decreased by 4.35 mmol/mol (P=.01). The patients spent 18.6 (SD 6.8) minutes on average using the app daily. After the intervention, the number of patients who measured their blood glucose level at least 3 times a day increased by 30%. The graphical visualization of the monitored parameters, automatic transmission of measured data from the glucometer, compatibility, and interconnection of individual devices when entering data were positively evaluated by patients. CONCLUSIONS: The Diani system was found to be beneficial for patients with type 1 diabetes mellitus in terms of managing their disease. Patients perceived it positively; it strengthened their knowledge of diabetes and their understanding of the influences of the measured values on the management of their disease. Its use had a positive effect on the HbA1c level.
- 590 __
- $a NEINDEXOVÁNO
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Muzik, Jan $u First Faculty of Medicine, Charles University, Prague, Czech Republic $u Department of Information and Communication Technologies in Medicine, Faculty of Biomedical Engineering, Czech Technical University in Prague, Praha, Czech Republic $1 https://orcid.org/0000000248517899
- 700 1_
- $a Holubová, Anna $u First Faculty of Medicine, Charles University, Prague, Czech Republic $u Department of Information and Communication Technologies in Medicine, Faculty of Biomedical Engineering, Czech Technical University in Prague, Praha, Czech Republic $1 https://orcid.org/0000000341096670
- 700 1_
- $a Fiala, Dominik $u First Faculty of Medicine, Charles University, Prague, Czech Republic $u Department of Information and Communication Technologies in Medicine, Faculty of Biomedical Engineering, Czech Technical University in Prague, Praha, Czech Republic $1 https://orcid.org/000000016523683X
- 700 1_
- $a Arsand, Eirik $u University of Tromsø - The Arctic University of Norway, Tromsø, Norway $u Norwegian Centre for E-health Research, Tromsø, Norway $1 https://orcid.org/0000000295201408
- 700 1_
- $a Urbanová, Jana $u Department of Internal Medicine, Faculty Hospital Kralovske Vinohrady, Center for Research in Diabetes, Metabolism and Nutrition, Charles University Third Faculty of Medicine, Prague, Czech Republic $1 https://orcid.org/0000000288606124
- 700 1_
- $a Janíčková Žďárská, Denisa $u Department of Internal Medicine, Second Medical Faculty, Charles University and Motol University Hospital, Prague, Czech Republic $1 https://orcid.org/0000000281437276
- 700 1_
- $a Brabec, Marek $u Institute of Computer Science, Academy of Science of the Czech Republic, Prague, Czech Republic $1 https://orcid.org/0000000163675791
- 700 1_
- $a Brož, Jan $u Department of Internal Medicine, Second Medical Faculty, Charles University and Motol University Hospital, Prague, Czech Republic $1 https://orcid.org/0000000324657333 $7 xx0046397
- 773 0_
- $w MED00209098 $t JMIR formative research $x 2561-326X $g Roč. 7, č. - (2023), s. e35064
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/37115601 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20230707 $b ABA008
- 991 __
- $a 20230721095410 $b ABA008
- 999 __
- $a ok $b bmc $g 1958550 $s 1196153
- BAS __
- $a 3
- BAS __
- $a PreBMC-PubMed-not-MEDLINE
- BMC __
- $a 2023 $b 7 $c - $d e35064 $e 20230428 $i 2561-326X $m JMIR formative research $n JMIR Form Res $x MED00209098
- LZP __
- $a Pubmed-20230707